» Articles » PMID: 8847140

Invasive Phenotype of MCF10A Cells Overexpressing C-Ha-ras and C-erbB-2 Oncogenes

Overview
Journal Int J Cancer
Specialty Oncology
Date 1995 Dec 11
PMID 8847140
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with erbB-2 (E) of Ha-ras (H) oncogene-transfected cells has been previously shown to cooperatively induce anchorage-independent growth of the MCF10A human mammary epithelial cell line in vitro, but not to induce nude mouse tumorigenicity. Here we show that oncogene-transformed MCF10A are able to halt in the lungs of nude mice, a sign of organ colonization potential. We have therefore studied the transformants for in vitro migratory and invasive properties known to correlate with the metastatic potential of human mammary carcinoma cells in nude mice. MCF10A transfected with Ha-ras, infected with a recombinant retroviral vector containing the human c-erB-2 proto-oncogene (MCF10A-HE cells), show a higher invasive index than either the single transfectant (MCF10A-H) or MCF10A-erB-2(MCF10A-E) cells in the Boyden chamber chemotaxis and chemoinvasion assays. The MCF10A-HE cells also adopted an invasive stellate growth pattern when plated or embedded in Matrigel, in contrast to the spherical colonies formed by the single transformants MCF10A-H, MCF10A-E, and the parental cells. Dot-blot analysis of gelatinase A and TIMP-2 mRNA levels revealed increasing gelatinase A mRNA levels (HE > E > H > MCF10A) and reduced TIMP-2 expression in both single and double transformants. Furthermore, MCF10A-HE cells show more MMP-2 activity than parental MCF10A cells or the single transformants. CD44 analysis revealed differential isoform banding for the MCF10A-HE cells compared to parental cells, MCF10A-H and MCF10A-E, accompanied by increased binding of hyaluronan by the double transformants. Our results indicate that erB-2 and Ha-ras co-expression can induce a more aggressive phenotype in vitro, representative of the malignancy of mammary carcinomas.

Citing Articles

HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells.

Cutano V, Di Giorgio E, Minisini M, Picco R, Dalla E, Brancolini C Mol Oncol. 2019; 13(8):1651-1668.

PMID: 31081251 PMC: 6670296. DOI: 10.1002/1878-0261.12503.


HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3.

Ruiz-Saenz A, Dreyer C, Campbell M, Steri V, Gulizia N, Moasser M Cancer Res. 2018; 78(13):3645-3658.

PMID: 29760043 PMC: 6779043. DOI: 10.1158/0008-5472.CAN-18-0430.


The size-speed-force relationship governs migratory cell response to tumorigenic factors.

Leal-Egana A, Letort G, Martiel J, Christ A, Vignaud T, Roelants C Mol Biol Cell. 2017; 28(12):1612-1621.

PMID: 28428257 PMC: 5469605. DOI: 10.1091/mbc.E16-10-0694.


IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines.

Thurber A, Nelson M, Frost C, Levin M, Brackenbury W, Kaplan D Oncotarget. 2017; 8(26):42382-42397.

PMID: 28415575 PMC: 5522074. DOI: 10.18632/oncotarget.16389.


Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Corominas-Faja B, Vellon L, Cuyas E, Buxo M, Martin-Castillo B, Serra D Histol Histopathol. 2016; 32(7):687-698.

PMID: 27714708 PMC: 5784426. DOI: 10.14670/HH-11-830.